MIRA INFORM REPORT

 

 

Report Date :

20.12.2013

 

IDENTIFICATION DETAILS

 

Name :

SUHEUNG CAPSULE CO LTD 

 

 

Registered Office :

61, Osongsaengmyeong-Ro, Osong-Eup, Cheongwon, 363951

 

 

Country :

South Korea

 

 

Financials (as on) :

31.12.2012

 

 

Date of Incorporation :

30.01.1973

 

 

Legal Form :

Public Independent

 

 

Line of Business :

Subject is engaged in the manufacture of capsules

 

 

No. of Employees :

651

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Status :

Satisfactory

 

 

Payment Behaviour :

No complaints

 

 

Litigation :

Clear

 

NOTES:

Any query related to this report can be made on e-mail: infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – March, 31st, 2013

 

Country Name

Previous Rating

(31.12.2012)

Current Rating

(31.03.2013)

South Korea

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

SOUTH KOREA - ECONOMIC OVERVIEW

 

South Korea over the past four decades has demonstrated incredible growth and global integration to become a high-tech industrialized economy. In the 1960s, GDP per capita was comparable with levels in the poorer countries of Africa and Asia. In 2004, South Korea joined the trillion dollar club of world economies, and is currently the world's 12th largest economy. Initially, a system of close government and business ties, including directed credit and import restrictions, made this success possible. The government promoted the import of raw materials and technology at the expense of consumer goods, and encouraged savings and investment over consumption. The Asian financial crisis of 1997-98 exposed longstanding weaknesses in South Korea's development model including high debt/equity ratios and massive short-term foreign borrowing. GDP plunged by 6.9% in 1998, and then recovered by 9% in 1999-2000. Korea adopted numerous economic reforms following the crisis, including greater openness to foreign investment and imports. Growth moderated to about 4% annually between 2003 and 2007. Korea''s export focused economy was hit hard by the 2008 global economic downturn, but quickly rebounded in subsequent years, reaching 6.3% growth in 2010. The US-South Korea Free Trade Agreement was ratified by both governments in 2011 and went into effect in March 2012. Throughout 2012 the economy experienced sluggish growth because of market slowdowns in the United States, China, and the Eurozone. The incoming administration in 2013, following the December 2012 presidential election, is likely to face the challenges of balancing heavy reliance on exports with developing domestic-oriented sectors, such as services. The South Korean economy''s long term challenges include a rapidly aging population, inflexible labor market, and heavy reliance on exports - which comprise half of GDP.

 

Source : CIA

 


Company name & address


 

SUHEUNG CAPSULE CO LTD 

                                                                                                                                                                                                                                                                                                                                                                           

 

61, Osongsaengmyeong-Ro, Osong-Eup

 

 

Cheongwon, 363951

Korea, Republic of

 

 

Tel:

82-43-2494100

Fax:

82-2-22172358

 

 www.suheung.com

 

Employees:

651

Company Type:

Public Independent

Traded:

Korea Stock Exchange:

008490

Incorporation Date:

30-Jan-1973

Auditor:

Sahmduk Accounting Corp.

Financials in:

               

 

 

Fiscal Year End:

31-Dec-2012

Reporting Currency:

South Korean Won

Annual Sales:

183.7  1

Net Income:

(3.8)

Total Assets:

437.4  2

Market Value:

435.5

 

(22-Nov-2013)

 

 

Business Description     

 

 

Suheung Capsule Co., Ltd. is a Korea-based company mainly engaged in the manufacture of capsules. The Company operates its business through two segments: capsule segment and gelatin segment. Its capsule segment mainly engages in the manufacture of hard capsules, soft capsules, health food, as well as paintballs and others. Its gelatin segment engages in the manufacture of gelatins and collagens, which are used as raw materials of capsules, adhesives, cosmetic and food. The Company distributes its products within domestic market and to overseas markets. On August 20, 2013, it merged with its wholly owned subsidiary, SHpharm, which is engaged in the production and distribution of medical products, and its subsidiary was be dissolved. For the six months ended 30 June 2013, Suheung Capsule Co Ltd revenues increased 29% to W133.22B. Net income increased 29% to W8.55B. Revenues reflect Capsule-Health Care segment increase of 33% to W72.15B, South Korea segment increase of 35% to W81.45B, Other Foreign segment increase of 20% to W51.76B. Net income also reflects Capsule-Health Care segment income increase from W3.75B to W8.03B.

 

 

Industry

 

 

Industry

Miscellaneous Chemical Manufacturing

ANZSIC 2006:

1899 - Other Basic Chemical Product Manufacturing Not Elsewhere Classified

ISIC Rev 4:

2029 - Manufacture of other chemical products n.e.c.

NACE Rev 2:

2059 - Manufacture of other chemical products n.e.c.

NAICS 2012:

325998 - All Other Miscellaneous Chemical Product and Preparation Manufacturing

UK SIC 2007:

2059 - Manufacture of other chemical products n.e.c.

US SIC 1987:

2899 - Chemicals and Chemical Preparations, Not Elsewhere Classified

 


Key Executives   

 

Name

Title

Ju Hwan Yang

Chairman of the Board, Chief Executive Officer

Seong Geol Yoon

President, Director

Geum Deok Park

Vice President

Yeong Geun Yoo

Internal Auditor

Sang Seon Kim

IR Contact Officer

 

 

Significant Developments

 

Topic

#*

Most Recent Headline

Date

Divestitures

1

Suheung Capsule Co Ltd to Sell Land and Building

18-Dec-2012

General Reorganization

1

Suheung Capsule Co Ltd to Merge with Subsidiary

19-Jun-2013

Equity Financing / Related

1

Suheung Capsule Co Ltd to Dispose Treasury Shares

20-Aug-2013

Equity Investments

4

Suheung Capsule Co Ltd Announces Change in Shareholding Structure

4-Nov-2013

Dividends

1

Suheung Capsule Co Ltd Declares Annual Cash Dividend for FY 2012

21-Feb-2013

* number of significant developments within the last 12 months

 

 

News   

 

Title

Date

USPTO Published Patent application of Suheung Capsule Co., Ltd. titled as "Non-animal soft capsule shell composition having improved disintegration and shell hardness". 
US Official News (201 Words)

18-Nov-2013

USPTO Published Patent application of Suheung Capsule Co., Ltd. titled as "Non-animal soft capsule shell composition having improved disintegration and shell hardness"
Plus Patent News (201 Words)

18-Nov-2013

Suheung Capsule Co Ltd to Merge with Subsidiary

Reuters UK (46 Words)

19-Jun-2013

Suheung Capsule Co Ltd Declares Annual Cash Dividend for FY 2012

Reuters UK (70 Words)

21-Feb-2013

 

 

 


Financial Summary

 

As of 30-Jun-2013

Key Ratios

Company

Industry

Current Ratio (MRQ)

1.36

2.09

Quick Ratio (MRQ)

0.68

1.48

Debt to Equity (MRQ)

1.37

0.43

Sales 5 Year Growth

17.06

4.13

 

 

Stock Snapshot

 

Traded: Korea Stock Exchange: 008490

 

As of 22-Nov-2013

   Financials in: KRW

Recent Price

40,000.00

 

EPS

-697.95

52 Week High

42,950.00

 

Price/Sales

2.24

52 Week Low

17,400.00

 

Dividend Rate

150.00

Avg. Volume (mil)

0.04

 

Price/Book

2.55

Market Value (mil)

462,764.50

 

Beta

0.56

 

Price % Change

Rel S&P 500%

4 Week

11.42%

12.98%

13 Week

11.11%

3.57%

52 Week

116.22%

104.72%

Year to Date

115.63%

114.64%

 

 

 

1 - Profit & Loss Item Exchange Rate: USD 1 = KRW 1126.849 

2 - Balance Sheet Item Exchange Rate: USD 1 = KRW 1066.4

 

 

Corporate Overview

 

Location
61, Osongsaengmyeong-Ro, Osong-Eup
Cheongwon, 363951
Korea, Republic of

 

Tel:

82-43-2494100

Fax:

82-2-22172358

 

www.suheung.com

Quote Symbol - Exchange

008490 - Korea Stock Exchange

Sales KRW(mil):

207,026.3

Assets KRW(mil):

466,466.9

Employees:

651

Fiscal Year End:

31-Dec-2012

 

 

 

Industry:

Chemical Manufacturing

Incorporation Date:

30-Jan-1973

Company Type:

Public Independent

Quoted Status:

Quoted

 

Chairman of the Board, Chief Executive Officer:

Ju Hwan Yang

 


Industry Codes

 

ANZSIC 2006 Codes:

1899

-

Other Basic Chemical Product Manufacturing Not Elsewhere Classified

 

ISIC Rev 4 Codes:

2029

-

Manufacture of other chemical products n.e.c.

 

NACE Rev 2 Codes:

2059

-

Manufacture of other chemical products n.e.c.

 

NAICS 2012 Codes:

325998

-

All Other Miscellaneous Chemical Product and Preparation Manufacturing

 

US SIC 1987:

2899

-

Chemicals and Chemical Preparations, Not Elsewhere Classified

 

UK SIC 2007:

2059

-

Manufacture of other chemical products n.e.c.

 

 

Business Description

 

Suheung Capsule Co., Ltd. is a Korea-based company mainly engaged in the manufacture of capsules. The Company operates its business through two segments: capsule segment and gelatin segment. Its capsule segment mainly engages in the manufacture of hard capsules, soft capsules, health food, as well as paintballs and others. Its gelatin segment engages in the manufacture of gelatins and collagens, which are used as raw materials of capsules, adhesives, cosmetic and food. The Company distributes its products within domestic market and to overseas markets. On August 20, 2013, it merged with its wholly owned subsidiary, SHpharm, which is engaged in the production and distribution of medical products, and its subsidiary was be dissolved. For the six months ended 30 June 2013, Suheung Capsule Co Ltd revenues increased 29% to W133.22B. Net income increased 29% to W8.55B. Revenues reflect Capsule-Health Care segment increase of 33% to W72.15B, South Korea segment increase of 35% to W81.45B, Other Foreign segment increase of 20% to W51.76B. Net income also reflects Capsule-Health Care segment income increase from W3.75B to W8.03B.

 

 

More Business Descriptions

 

Manufacture of gelatine capsules

Pharmaceutical and Medicine Manufacturing

 

 


Financial Data

 

Financials in:

KRW(mil)

 

Revenue:

207,026.3

Net Income:

-4,335.2

Assets:

466,466.9

Long Term Debt:

177,374.8

 

Total Liabilities:

289,230.8

 

Working Capital:

-4.1

 

 

 

Date of Financial Data:

31-Dec-2012

 

1 Year Growth

10.2%

NA

7.4%

 

 

Market Data

 

Quote Symbol:

008490

Exchange:

Korea Stock Exchange

Currency:

KRW

Stock Price:

40,000.0

Stock Price Date:

11-22-2013

52 Week Price Change %:

116.2

Market Value (mil):

462,764,512.0

 

SEDOL:

B123VD3

ISIN:

KR7008490005

 

Equity and Dept Distribution:

FY'00 cash flow is unavailable. FY'98,'99,'04 &'05 financials reflect non-consolidated numbers. FY'00-'03,'06-'09, financials areconsolidated numbers. 04/2006, 2-for-1 stock split. FY'08 I/S CLA.

 

 

Key Corporate Relationships

 

Auditor:

Sahmduk Accounting Corp.

 

Auditor:

Sahmduk Accounting Corp.

 

 

 

 

 

Strengths/Weaknesses (SWOT)

 

 

Helpful 
to achieving the objective

Harmful 
to achieving the objective

Internal Origin
(attributes of the organization)

Strengths

Improved Liquidity

Wide Geographical Presence

Broad Product Offerings

Weaknesses

Decreasing Profitability

Substantial Presence of Debt

External Origin
(attributes of the environment)

Opportunities

Changing Demographics

New Production Facility

Threats

Competitive Pressures

Stringent Government Regulations

 

 

 

Overview

 

Suheung Capsule Co., Ltd. (Suheung) is a Korea-based company that manufactures and sells capsule products. The company’s products include hard capsules, softgel capsules and paintballs. Suheung leverages its diverse range of product offerings and wide geographical presence to sustain its competitive market position, and financial strength. New production plant and changing demographics could provide new growth avenues to the company. However, increasing competitive pressures, uncertain R&D outcomes and stringent government regulations could affect the company’s business operations and profitability in the future.

 

 

Strengths

 

Improved Liquidity

Suheung reported improved liquidity position in 2012. For the fiscal year ended December 2012, the company reported current assets of KRW124,349.51m, indicating an increase of 30.28% over KRW95,449.63m in 2011. In fiscal 2012, the company’s cash and equivalents increased with 56.79% to KRW6,832.33m, as compared to KRW4,357.72m in 2011. For the fiscal year ended 2012, the company reported account receivables of KRW48,096.64m. In fiscal 2012, the company reported inventory of KRW64,799m. Suheung reported current liabilities of KRW77,674.85m, indicating a decrease of 27.28% over KRW106,812.69m in 2011. Increased current assets and decreased current liabilities contributed to increased working capital of the company. In fiscal 2012, the company reported working capital of KRW46,674.66m. As a result, the company’s liquidity ratios increased in fiscal 2012. The company reported current ratio and cash ratio of 1.60 and 0.10 in 2012 as compared to 0.89 and 0.04 respectively in 2011.

 

Wide Geographical Presence

A wide geographical presence helps the company mitigate the various risks associated with overdependence on a particular market. Suheung operates in South Korea and has international operations across five continents in Europe, Asia, Middle East, Africa and Americas. It has manufacturing facilities in Korea and Vietnam. Suheung markets its products through its international sales network in more than 50 countries across the world. The company has sales companies, sales agents and distributors in various European countries and other regions. The company’s geographical diversity helped it sustain revenue growth. A wide geographical presence enables the company to expand its operations, as wider reach in terms of geography would lead to more benefits, improved profit margins, economies of scale and recognition on a worldwide basis.

 

Broad Product Offerings

Suheung’s manufacturing capabilities enable the company to offer a diverse range of products for sale to pharmaceutical companies and food supplement markets worldwide. Known for their excellence in product stability, lubricity and resistance against damage; the company categorized its product offerings into three forms, namely, hard capsules, softgel capsules and paintballs. Leveraging its world-class and cGMP certified manufacturing facilities; the company manufactures a variety of capsule products, including HPMC (vegetarian) capsules; and fish-based gelatin capsules. Suheung markets hard capsules under the brand name EMBO CAPS. Suheung manufactures high quality soft gelatin capsules for the pharmaceutical companies and food supplement makers. The company manufactures paintballs utilizing state-of-the-art, fully automated paintball production systems. The company offers contract manufacturing and R&D services. Suheung’s manufacturing processes and quality management procedures have compliance with cGMP and other international standards, ensuring the excellence and overall quality of its products.

Weaknesses

 

Decreasing Profitability

The company showed a low profitability in its operation in 2012. Although, the company's revenue increased with 10.2% to KRW207,026.30m in 2012 from KRW187,868.82m of 2011. The company reported gross profit of KRW40,281.86m, indicating a decrease of 15.57% over KRW47,709.95m in 2011. The company's operating expense increased with 19.66% to KRW192,600.64m in 2012 from KRW160,958.87m in 2011; while its operating income decreased with 46.39% to KRW14,425.66m in 2012 from KRW26909.95m in 2011. In 2012, the company's gross margin, operating margin and net profit margin decreased to 19.45% and 6.96% from 25.39% and 14.32% in 2011. In 2012, the company reported negative returns of 2.44% on equity, as compared to 9.56% in 2011; and negative return on assets of 0.92% as compared to 4.13% in 2011. The company's weak profitability position highlights its operational inefficiency.

 

Substantial Presence of Debt

Substantial debt can result in delayed investment and capital expenditure, and compel the company to sell assets to procure additional capital to meet growth and operational needs; and restructure and refinance its debt to survive in the dynamic business environment. As of December 31, 2012, the company’s total debt stood at KRW229.34 billion, reflecting an increase of 15.74% over KRW198.15 billion in 2011. As a result, in fiscal year 2012, it reported debt to equity ratio of 129.39% and net debt to equity of 125.54% as compared to 105.59% and 103.27% respectively in 2011. Any reduction in revenue and operating cash flow could hinder the company’s ability to repay interest and principal, resulting in defaults. Such huge debt burden could lead to credit crisis in future, affecting the financial performance of the company in the long run.

 

 

Opportunities

 

Changing Demographics

The increasing population of people aged above 60, who consume more medical solutions than the younger population and are more prone to chronic diseases, holds significant market potential for the company. The United Nations Population Division estimated that the number of people aged above 60 years throughout the world will triple to nearly 2 billion by 2050. Globally, the population of older persons is growing at a rate of 2.6% annually. According to the United Nations Population Division, people aged 60 are projected to account for 22% of the total world population by 2050, up from 11% in 2009. In developed economies such as the US, the UK, France, Germany and Japan, the percentage of people aged 65 and older is in double digits and is expected to continue to grow for the next seven years. While developed countries have managed to slow down their overall population growth, the longevity in the elderly population will cause concern in the future. Such a situation will increase the healthcare costs in those countries. The pace of population aging is faster in developing countries than in developed countries. Due to the large volume of the overall population in countries such as China and India, the number of people becoming older is quite high. In 2009, the number of persons aged above 60 increased three and a half times to 737 million globally. There were 12 countries with more than 10 million people each aged above 60, including China (160 million), India (89 million), the US (56 million), Japan (38 million), the Russian Federation (25 million) and Germany (21 million). By 2050, 32 countries are expected to have over 10 million people each aged above 60, including five countries with more than 50 million older people: China (440 million), India (316 million), the US (111 million), Indonesia (72 million) and Brazil (64 million). Such elderly population is expected to exert increasing pressure on the healthcare system.

 

New Production Facility

The company focuses on increasing its production capacities for hard capsule manufacturing business and to offer contract manufacturing facilities. In September 2012, the company opened new production plant in Osong Biohealth Technopolis. The palnt has combined floor space of more than 92,000 square meters (990,280 square feet). The company started the construction of this plant in 2010. The new plant is a part of the company’s relocation strategy. The new plant will serve as the technical core of the company’s hard capsule manufacturing business. The new plant has double production capacity and will also provide contract manufacturing services for hard shells and softgels, and other dosages. The increase in production capacity will enable it to meet the increasing demand in the overseas markets. Strategic initiatives such as this could provide it opportunities for growth and business development.

 

 

Threats

 

Competitive Pressures

The company’s markets are characterized by intense competition, evolving industry standards and business models. The demand for its products depends on the competitive atmosphere, including the timely development and introduction of new and competitive products and the company’s response to downward pricing to sustain competition. The competitors of the company have greater experience, research and development capabilities, greater manufacturing, marketing, financial, and managerial resources than the company. Suheung also competes with other international companies entering the Korean capsule production industry. Factors including changes in customer order patterns, changing incentive programs or competitors’ new products could impact the company’s competitive ability.

 

Stringent Government Regulations

Increased regulation of the drug market could impact the company’s costs by increasing the time and cost of bringing capsule products into the market. Suheung is regulated by the Korea Food and Drug Administration (KFDA). Established in 1996-97, the KFDA is an independent agency, under the Ministry of Health and Welfare (MOHW), responsible ensuring the safety and efficacy of foods, pharmaceuticals, medical devices and cosmetics, and supporting the development of the food and pharmaceutical industries. The company’s products are subject to various local, state, federal, foreign and transnational laws and regulations. In the US, the FDA and in Europe, the EMEA regulate the introduction of new medical products, besides the manufacturing, labeling and record keeping procedures for such products. Receiving marketing approval for new medical devices from the US FDA is time consuming and expensive. Products distributed outside the US are also subject to government regulations, which vary from country to country. The company has to comply with different regulations governing product standards, packaging and labeling requirements, import restrictions, tariff regulations and tax requirements. Non-compliance by the company with applicable laws and regulations or failure to maintain, renew or obtain necessary permits and licenses could have an adverse effect on the company's results of operations and financial performance.

 

 

Competitors Report

 

CompanyName

Location

Employees

Ownership

Anhui Huangshan Capsule Co.,Ltd.

Xuancheng, Anhui, China

760

Private

Capsugel, Inc.

Morristown, New Jersey, United States

20

Private

Fuji Capsule Co., Ltd.

Fujinomiya-Shi, Japan

280

Private

Qualicaps Co., Ltd. - Global Headquarters

Irving, Texas, United States

9

Private

 

 

 


Executives Report

 

Board of Directors

 

 

Name

Title

Function

 

Ju Hwan Yang

 

Chairman of the Board, Chief Executive Officer

Chairman

 

Biography:

Yang Ju Hwan is Chairman of the Board and Chief Executive Officer of Suheung Capsule Co., Ltd. Yang is also Chairman in another Korea-based company. Previously, Yang was Chief Executive Officer of SEOHEUNG METAL. Yang holds a Bachelor's degree in Electronic Engineering from Yonsei University, Korea. Yang holds an Honorary Doctorate's degree in Pharmacy from Chung-Ang University, Korea.

 

Age: 61

 

Education:

Yonsei University, B (Electronic Engineering)

 

Byeong Gil Lee

 

Non-Executive Independent Director

 

 

 

Biography:

Lee Byeong Gil is Non-Executive Independent Director in Suheung Capsule Co., Ltd. Lee is also Chief Executive Officer in Taeyoung Accounting Corporation. Lee holds a Bachelor's degree and a Doctorate's degree in Business Administration from Korea University and Myongji University, Korea. Lee is a Certified Public Accountant.

 

Age: 75

 

Education:

Myongji University, PHD (Business Administration)

Korea University, B (Business Administration)

 

 

 

Executives

 

Name

Title

Function

Ju Hwan Yang

 

Chairman of the Board, Chief Executive Officer

Chief Executive Officer

Biography:

Yang Ju Hwan is Chairman of the Board and Chief Executive Officer of Suheung Capsule Co., Ltd. Yang is also Chairman in another Korea-based company. Previously, Yang was Chief Executive Officer of SEOHEUNG METAL. Yang holds a Bachelor's degree in Electronic Engineering from Yonsei University, Korea. Yang holds an Honorary Doctorate's degree in Pharmacy from Chung-Ang University, Korea.

 

Age: 61

 

Education:

Yonsei University, B (Electronic Engineering)

 

Seong Geol Yoon

 

President

President

Seong Geol Yoon

 

President, Director

President

Biography:

Yoon Seong Geol has been President and Director of Suheung Capsule Co., Ltd. Prior to the current position, Yoon served as Managing Director and Vice President of the Company. Yoon received a Bachelor's degree in Mechanical Engineering from Kyungpook National University, Korea.

 

Age: 61

 

Education:

Kyungpook National University, B (Mechanical Engineering)

 

Seong Jun Cho

 

Managing Director

Managing Director

Age: 56

 

Byeong Guk Choi

 

Assistant Managing Director

Managing Director

Sang Jo Han

 

Assistant Managing Director

Managing Director

Age: 52

 

Tae Dong Kim

 

Assistant Managing Director

Managing Director

Bae Seong Kim

 

Assistant Managing Director

Managing Director

Age: 62

 

Education:

Dankook University, M (Business Administration)

 

Jong Suk Park

 

Managing Director

Managing Director

Age: 59

 

Geum Deok Park

 

Vice President

Senior Management (General)

Age: 54

 

Yeong Geun Yoo

 

Internal Auditor

Accounting Executive

Biography:

Yoo Yeong Geun has been Internal Auditor in SUHEUNG CAPSULE CO.,LTD since March 4, 2011. Previously, Yoo worked for Korindo Group. Yoo received a Bachelor's degree from Hankuk University of Foreign Studies, Korea.

 

Age: 59

 

Education:

Hankuk University of Foreign Studies, B 

 

Sang Seon Kim

 

IR Contact Officer

Investor Relations Executive

 

 

Significant Developments

 

 

Suheung Capsule Co Ltd Announces Change in Shareholding Structure

Nov 04, 2013


Suheung Capsule Co Ltd announced that TrustonAsset Management has acquired 590,070 shares of the Company, representing a 5.10% stake. 

Suheung Capsule Co Ltd Announces Changes in Shareholding Structure

Sep 11, 2013


Suheung Capsule Co Ltd announced that Baring Asset Management Korea Co., Ltd. has acquired 586,960 shares of the Company, representing a 5.07% stake. 

Suheung Capsule Co Ltd to Dispose Treasury Shares

Aug 20, 2013


Suheung Capsule Co Ltd announced that it will sell 250,000 shares of its common stock for KRW 9,037,500,000 from August 21 to August 22, 2013, to improve its capital efficiency and increase floating supply of stocks. 

Suheung Capsule Co Ltd to Merge with Subsidiary

Jun 19, 2013


Suheung Capsule Co Ltd announced that it will merge with its wholly owned subsidiary, SHpharm, which is engaged in the engaged in the production and distribution of medical products, with the Company to survive and the subsidiary to be dissolved, effective August 20, 2013. 

Suheung Capsule Co Ltd Announces Changes in Shareholding Structure

Apr 24, 2013


Suheung Capsule Co Ltd announced that Shinyoung Securities Co., Ltd. has acquired 580,659 shares of the Company, representing a 5.02% stake. 

Suheung Capsule Co Ltd Announces Changes in Shareholding Structure

Apr 09, 2013


Suheung Capsule Co Ltd announced that National Pension Service has acquired 579,780 shares of the Company, representing a 5.01% stake. 

Suheung Capsule Co Ltd Declares Annual Cash Dividend for FY 2012

Feb 21, 2013


Suheung Capsule Co Ltd announced that it has declared an annual cash dividend of KRW 150 per share of common stock to shareholders of record on December 31, 2012 for the fiscal year 2012. The dividend rate of market price is 0.8% and the total amount of the cash dividend is KRW 1,697,866,950. The Company's annual cash dividend for the fiscal year 2011 was KRW 280 per share. 

Suheung Capsule Co Ltd to Sell Land and Building

Dec 18, 2012


Suheung Capsule Co Ltd announced that it will sell its land measuring 19,675.94 square meters and building, located in Bucheon City, for KRW 45,745 million, to a Korea-based company. The expected transaction settlement date is December 20, 2013. 

 

 

News

 

USPTO Published Patent application of Suheung Capsule Co., Ltd. titled as "Non-animal soft capsule shell composition having improved disintegration and shell hardness". 

US Official News (201 Words)

18-Nov-2013

USPTO Published Patent application of Suheung Capsule Co., Ltd. titled as "Non-animal soft capsule shell composition having improved disintegration and shell hardness"

Plus Patent News (201 Words)

18-Nov-2013

Suheung Capsule Co Ltd to Merge with Subsidiary

Reuters UK (46 Words)

19-Jun-2013

Suheung Capsule Co Ltd Declares Annual Cash Dividend for FY 2012

Reuters UK (70 Words)

21-Feb-2013

Annual Income Statement


Financials in: USD (mil)

Except for share items (millions) and per share items (actual units)

 

Financial Glossary

 

 

 

 

 

 

31-Dec-2012

31-Dec-2011

31-Dec-2010

31-Dec-2009

31-Dec-2008

Period Length

12 Months

12 Months

12 Months

12 Months

12 Months

UpdateType/Date

Updated Normal 
31-Dec-2012

Reclassified Normal 
31-Dec-2012

Restated Normal
31-Dec-2011

Updated Normal 
31-Dec-2009

Reclassified Normal 
31-Dec-2009

Filed Currency

KRW

KRW

KRW

KRW

KRW

Exchange Rate (Period Average)

1126.848795

1107.891393

1156.281981

1276.385219

1100.562842

Auditor

Sahmduk Accounting Corp.

Sahmduk Accounting Corp.

Sahmduk Accounting Corp.

Sahmduk Accounting Corp.

Sungshin Accounting Corp.

Auditor Opinion

Unqualified with Explanation

Unqualified with Explanation

Unqualified with Explanation

Unqualified

Unqualified

 

 

 

 

 

 

    Net Sales

183.7

169.6

144.3

114.5

110.3

Revenue

183.7

169.6

144.3

114.5

110.3

Total Revenue

183.7

169.6

144.3

114.5

110.3

 

 

 

 

 

 

    Cost of Revenue

148.0

126.5

105.1

81.7

79.6

Cost of Revenue, Total

148.0

126.5

105.1

81.7

79.6

Gross Profit

35.7

43.1

39.2

32.8

30.7

 

 

 

 

 

 

    Selling/General/Administrative Expense

12.4

11.2

11.3

7.9

6.7

    Labor & Related Expense

7.8

6.7

5.0

4.5

4.6

    Advertising Expense

0.4

0.4

0.4

0.2

0.3

Total Selling/General/Administrative Expenses

20.6

18.3

16.7

12.6

11.6

Research & Development

1.9

-

-

-

-

    Depreciation

0.4

0.4

0.4

0.5

0.5

    Amortization of Intangibles

-

-

-

0.5

0.5

Depreciation/Amortization

0.4

0.4

0.4

0.9

1.1

Total Operating Expense

170.9

145.3

122.2

95.3

92.3

 

 

 

 

 

 

Operating Income

12.8

24.3

22.1

19.2

18.1

 

 

 

 

 

 

        Interest Expense - Non-Operating

-8.4

-4.0

-3.3

-3.9

-5.4

    Interest Expense, Net Non-Operating

-8.4

-4.0

-3.3

-3.9

-5.4

        Interest Income - Non-Operating

0.2

1.5

0.8

0.6

1.5

        Investment Income - Non-Operating

-0.1

0.7

-5.8

-1.1

-1.0

    Interest/Investment Income - Non-Operating

0.1

2.2

-4.9

-0.5

0.4

    Interest Income (Expense) - Net Non-Operating

0.0

0.0

0.0

-

-

Interest Income (Expense) - Net Non-Operating Total

-8.3

-1.8

-8.2

-4.5

-5.0

Gain (Loss) on Sale of Assets

4.9

-0.4

4.2

-0.3

-0.1

    Other Non-Operating Income (Expense)

-14.4

0.0

0.5

0.6

1.1

Other, Net

-14.4

0.0

0.5

0.6

1.1

Income Before Tax

-5.0

22.1

18.6

15.0

14.0

 

 

 

 

 

 

Total Income Tax

-2.9

4.4

4.2

4.6

4.2

Income After Tax

-2.1

17.7

14.5

10.4

9.8

 

 

 

 

 

 

    Minority Interest

-1.7

-1.5

-1.4

-0.7

-0.1

Net Income Before Extraord Items

-3.8

16.2

13.0

9.7

9.7

Net Income

-3.8

16.2

13.0

9.7

9.7

 

 

 

 

 

 

Income Available to Common Excl Extraord Items

-3.8

16.2

13.0

9.7

9.7

 

 

 

 

 

 

Income Available to Common Incl Extraord Items

-3.8

16.2

13.0

9.7

9.7

 

 

 

 

 

 

Basic/Primary Weighted Average Shares

11.3

11.2

11.1

10.8

10.7

Basic EPS Excl Extraord Items

-0.34

1.45

1.18

0.89

0.90

Basic/Primary EPS Incl Extraord Items

-0.34

1.45

1.18

0.89

0.90

Dilution Adjustment

0.0

0.0

0.0

0.0

0.1

Diluted Net Income

-3.8

16.2

13.0

9.7

9.7

Diluted Weighted Average Shares

11.3

11.2

11.1

10.8

11.1

Diluted EPS Excl Extraord Items

-0.34

1.45

1.18

0.89

0.88

Diluted EPS Incl Extraord Items

-0.34

1.45

1.18

0.89

0.88

Dividends per Share - Common Stock Primary Issue

0.13

0.25

0.24

0.20

0.21

Gross Dividends - Common Stock

1.5

2.9

2.7

2.2

2.2

Interest Expense, Supplemental

8.4

4.0

3.3

3.9

5.4

Depreciation, Supplemental

13.1

7.0

7.7

8.1

6.7

Total Special Items

-4.9

0.4

-4.2

0.8

0.7

Normalized Income Before Tax

-9.9

22.5

14.4

15.7

14.7

 

 

 

 

 

 

Effect of Special Items on Income Taxes

-1.7

0.1

-0.9

0.1

0.0

Inc Tax Ex Impact of Sp Items

-4.6

4.4

3.2

4.7

4.3

Normalized Income After Tax

-5.3

18.0

11.2

11.0

10.4

 

 

 

 

 

 

Normalized Inc. Avail to Com.

-7.0

16.5

9.8

10.3

10.3

 

 

 

 

 

 

Basic Normalized EPS

-0.62

1.48

0.88

0.95

0.96

Diluted Normalized EPS

-0.62

1.48

0.88

0.95

0.94

Amort of Acquisition Costs, Supplemental

-

-

-

0.5

0.5

Amort of Intangibles, Supplemental

0.0

0.0

0.0

0.0

0.0

Rental Expenses

1.2

1.3

0.9

0.6

0.4

Advertising Expense, Supplemental

0.4

0.4

0.4

0.2

0.3

Research & Development Exp, Supplemental

1.9

-

-

-

-

Normalized EBIT

12.8

24.3

22.1

19.2

18.1

Normalized EBITDA

26.0

31.3

29.9

27.8

25.4

 

 

Annual Balance Sheet

 

Financials in: USD (mil)

 

Financial Glossary

 

 

 

31-Dec-2012

31-Dec-2011

31-Dec-2010

31-Dec-2009

31-Dec-2008

UpdateType/Date

Updated Normal 
31-Dec-2012

Updated Normal 
31-Dec-2011

Restated Normal 
31-Dec-2011

Updated Normal 
31-Dec-2009

Reclassified Normal 
31-Dec-2009

Filed Currency

KRW

KRW

KRW

KRW

KRW

Exchange Rate

1066.400024

1152

1134.9

1164.475

1259.55

Auditor

Sahmduk Accounting Corp.

Sahmduk Accounting Corp.

Sahmduk Accounting Corp.

Sahmduk Accounting Corp.

Sungshin Accounting Corp.

Auditor Opinion

Unqualified with Explanation

Unqualified with Explanation

Unqualified with Explanation

Unqualified

Unqualified

 

 

 

 

 

 

    Cash & Equivalents

6.4

3.8

5.9

4.2

3.4

    Short Term Investments

1.5

-

0.3

3.4

14.8

Cash and Short Term Investments

7.9

3.8

6.1

7.6

18.2

        Accounts Receivable - Trade, Gross

45.5

29.3

35.9

32.4

25.3

        Provision for Doubtful Accounts

-0.5

-0.4

-0.5

-0.7

-0.4

    Trade Accounts Receivable - Net

45.1

28.9

35.4

31.9

25.3

    Other Receivables

1.8

1.7

1.5

3.1

3.1

Total Receivables, Net

46.9

30.6

36.9

35.0

28.5

    Inventories - Finished Goods

24.4

18.3

18.6

15.8

12.3

    Inventories - Work In Progress

6.8

6.6

3.2

2.0

1.9

    Inventories - Raw Materials

22.9

17.0

12.9

9.1

10.5

    Inventories - Other

6.7

6.3

3.1

6.2

1.8

Total Inventory

60.8

48.3

37.8

33.1

26.4

Prepaid Expenses

1.1

0.2

0.0

2.0

2.3

    Deferred Income Tax - Current Asset

-

-

-

0.4

0.1

    Other Current Assets

0.0

0.0

1.1

0.7

-

Other Current Assets, Total

0.0

0.0

1.1

1.1

0.1

Total Current Assets

116.6

82.9

82.1

78.7

75.6

 

 

 

 

 

 

        Buildings

110.1

42.5

34.2

36.0

33.6

        Land/Improvements

73.3

113.5

111.6

42.5

25.6

        Machinery/Equipment

154.9

100.0

95.6

96.6

83.5

        Construction in Progress

5.6

97.6

33.6

8.4

16.9

        Other Property/Plant/Equipment

20.9

12.0

11.6

11.6

8.6

    Property/Plant/Equipment - Gross

364.9

365.5

286.5

195.2

168.2

    Accumulated Depreciation

-104.1

-95.1

-92.1

-85.7

-70.9

Property/Plant/Equipment - Net

260.8

270.4

194.4

109.6

97.3

Goodwill, Net

-

-

-

1.0

1.3

Intangibles, Net

6.1

5.8

5.2

8.9

7.8

    LT Investment - Affiliate Companies

7.2

6.6

5.7

4.6

6.3

    LT Investments - Other

1.7

4.9

5.0

3.8

1.9

Long Term Investments

9.0

11.5

10.7

8.3

8.2

Note Receivable - Long Term

0.2

4.8

4.4

8.6

8.6

    Deferred Income Tax - Long Term Asset

0.1

-

-

1.9

1.8

    Discontinued Operations - Long Term Asset

42.9

-

-

-

-

    Other Long Term Assets

1.8

1.6

1.5

2.3

3.2

Other Long Term Assets, Total

44.7

1.6

1.5

4.2

5.0

Total Assets

437.4

376.9

298.2

219.2

203.8

 

 

 

 

 

 

Accounts Payable

12.1

1.5

8.7

1.0

4.7

Accrued Expenses

1.9

1.5

0.7

0.7

0.6

Notes Payable/Short Term Debt

44.2

70.0

58.3

21.8

31.6

Current Portion - Long Term Debt/Capital Leases

4.6

13.9

12.5

33.9

7.6

    Customer Advances

4.5

0.3

-

1.0

2.7

    Income Taxes Payable

1.9

0.6

3.5

4.3

1.3

    Other Payables

3.5

3.8

1.6

7.6

1.5

    Deferred Income Tax - Current Liability

-

-

-

-

0.4

    Other Current Liabilities

0.3

1.1

0.4

0.2

0.1

Other Current liabilities, Total

10.1

5.7

5.5

13.1

6.0

Total Current Liabilities

72.8

92.7

85.6

70.4

50.5

 

 

 

 

 

 

    Long Term Debt

165.8

88.0

26.3

28.3

49.4

    Capital Lease Obligations

0.5

-

2.4

-

-

Total Long Term Debt

166.3

88.0

28.6

28.3

49.4

Total Debt

215.1

172.0

99.4

84.0

88.7

 

 

 

 

 

 

    Deferred Income Tax - LT Liability

9.7

14.2

12.5

-

0.0

Deferred Income Tax

9.7

14.2

12.5

-

0.0

Minority Interest

21.3

18.4

17.8

12.3

9.6

    Pension Benefits - Underfunded

0.9

0.3

0.1

2.3

2.9

    Other Long Term Liabilities

0.2

0.4

1.5

1.7

1.7

Other Liabilities, Total

1.1

0.6

1.6

4.0

4.7

Total Liabilities

271.2

214.0

146.2

115.0

114.2

 

 

 

 

 

 

    Common Stock

5.7

5.3

5.4

5.2

4.7

Common Stock

5.7

5.3

5.4

5.2

4.7

Additional Paid-In Capital

7.6

7.1

7.2

10.4

8.1

Retained Earnings (Accumulated Deficit)

123.8

122.4

111.9

63.6

50.9

Treasury Stock - Common

-1.2

-1.2

-2.3

-2.3

-2.1

Unrealized Gain (Loss)

28.4

26.3

26.6

27.7

25.6

    Translation Adjustment

-2.1

-0.8

0.1

0.0

2.4

    Other Equity

4.1

3.8

3.2

-0.5

0.0

Other Equity, Total

2.0

3.0

3.3

-0.4

2.3

Total Equity

166.2

162.9

152.0

104.2

89.6

 

 

 

 

 

 

Total Liabilities & Shareholders’ Equity

437.4

376.9

298.2

219.2

203.8

 

 

 

 

 

 

    Shares Outstanding - Common Stock Primary Issue

11.3

11.3

11.1

11.1

10.7

Total Common Shares Outstanding

11.3

11.3

11.1

11.1

10.7

Treasury Shares - Common Stock Primary Issue

0.3

0.3

0.5

0.5

0.5

Employees

674

598

564

556

539

Number of Common Shareholders

-

2,423

2,323

2,532

2,369

Accumulated Goodwill Amortization Suppl.

-

-

-

1.6

-

Accumulated Intangible Amort, Suppl.

1.1

1.0

1.0

0.0

-

Deferred Revenue - Current

4.5

0.3

-

1.0

2.7

Total Long Term Debt, Supplemental

86.5

102.0

-

62.2

48.4

Long Term Debt Maturing within 1 Year

4.6

13.9

-

33.9

6.0

Long Term Debt Maturing in Year 2

9.2

29.5

-

13.1

15.2

Long Term Debt Maturing in Year 3

15.8

6.1

-

14.8

7.9

Long Term Debt Maturing in Year 4

11.0

8.8

-

-

-

Long Term Debt Maturing in 2-3 Years

25.0

35.6

-

27.9

23.1

Long Term Debt Maturing in 4-5 Years

11.0

8.8

-

-

-

Long Term Debt Matur. in Year 6 & Beyond

46.0

43.6

-

0.3

19.4

Total Capital Leases, Supplemental

0.5

1.0

2.4

-

0.0

Capital Lease Payments Due in Year 1

0.0

1.0

0.9

-

0.0

Capital Lease Payments Due in Year 2

0.1

-

0.4

-

0.0

Capital Lease Payments Due in Year 3

0.1

-

0.4

-

-

Capital Lease Payments Due in Year 4

0.1

-

0.4

-

-

Capital Lease Payments Due in Year 5

0.1

-

0.4

-

-

Capital Lease Payments Due in 2-3 Years

0.3

-

0.7

-

0.0

Capital Lease Payments Due in 4-5 Years

0.3

-

0.7

-

-

Total Operating Leases, Supplemental

0.2

0.4

-

-

-

Operating Lease Payments Due in Year 1

0.2

0.2

-

-

-

Operating Lease Payments Due in Year 2

0.0

0.1

-

-

-

Operating Lease Payments Due in Year 3

0.0

0.1

-

-

-

Operating Lease Payments Due in Year 4

0.0

0.1

-

-

-

Operating Lease Payments Due in Year 5

0.0

0.1

-

-

-

Operating Lease Pymts. Due in 2-3 Years

0.0

0.1

-

-

-

Operating Lease Pymts. Due in 4-5 Years

0.0

0.1

-

-

-

Oper. Lse. Pymts. Due in Year 6 & Beyond

0.0

0.0

-

-

-

 

 


Annual Cash Flows

 

Financials in: USD (mil)

 

Financial Glossary

 

 

 

 

31-Dec-2012

31-Dec-2011

31-Dec-2010

31-Dec-2009

31-Dec-2008

Period Length

12 Months

12 Months

12 Months

12 Months

12 Months

UpdateType/Date

Updated Normal 
31-Dec-2012

Updated Normal 
31-Dec-2011

Restated Normal 
31-Dec-2011

Updated Normal 
31-Dec-2009

Updated Normal 
31-Dec-2008

Filed Currency

KRW

KRW

KRW

KRW

KRW

Exchange Rate (Period Average)

1126.848795

1107.891393

1156.281981

1276.385219

1100.562842

Auditor

Sahmduk Accounting Corp.

Sahmduk Accounting Corp.

Sahmduk Accounting Corp.

Sahmduk Accounting Corp.

Sungshin Accounting Corp.

Auditor Opinion

Unqualified with Explanation

Unqualified with Explanation

Unqualified with Explanation

Unqualified

Unqualified

 

 

 

 

 

 

Net Income/Starting Line

-2.1

17.7

14.5

10.4

9.8

    Depreciation

13.1

7.0

7.7

8.1

6.7

Depreciation/Depletion

13.1

7.0

7.7

8.1

6.7

    Amortization of Intangibles

0.0

0.0

0.0

0.5

0.6

Amortization

0.0

0.0

0.0

0.5

0.6

Deferred Taxes

-0.2

2.5

-0.5

-0.5

-0.4

    Discontinued Operations

16.8

-

-

-

-

    Unusual Items

-4.9

0.5

-2.6

1.1

0.1

    Equity in Net Earnings (Loss)

-0.9

-2.0

2.4

0.2

-

    Other Non-Cash Items

7.5

7.1

9.1

3.0

1.5

Non-Cash Items

18.5

5.6

8.9

4.3

1.7

    Accounts Receivable

5.7

5.0

1.8

-3.2

-0.3

    Inventories

-8.6

-10.7

-5.4

-4.3

-5.0

    Prepaid Expenses

0.0

0.0

0.0

0.5

-1.1

    Other Assets

-1.8

-0.3

0.2

0.0

-

    Accounts Payable

-5.0

-7.1

1.2

3.3

-1.8

    Accrued Expenses

-

-

-

0.0

0.0

    Taxes Payable

-

-

0.6

2.7

-2.9

    Other Liabilities

-4.1

-1.6

-5.7

-3.1

1.1

    Other Assets & Liabilities, Net

0.0

-

-

-

-

    Other Operating Cash Flow

-9.1

-8.5

-7.3

-

-

Changes in Working Capital

-22.8

-23.3

-14.5

-4.2

-10.0

Cash from Operating Activities

6.6

9.6

16.1

18.6

8.4

 

 

 

 

 

 

    Purchase of Fixed Assets

-45.7

-90.5

-46.8

-18.3

-33.1

    Purchase/Acquisition of Intangibles

0.0

-0.9

-0.7

-0.7

-1.3

Capital Expenditures

-45.8

-91.4

-47.5

-19.0

-34.3

    Sale of Fixed Assets

11.9

0.4

10.2

0.3

7.4

    Sale/Maturity of Investment

4.5

7.9

6.8

25.3

25.4

    Purchase of Investments

-5.8

-7.9

-6.5

-15.4

-19.7

    Other Investing Cash Flow

4.6

1.0

-

-0.6

0.1

Other Investing Cash Flow Items, Total

15.2

1.4

10.4

9.5

13.2

Cash from Investing Activities

-30.6

-90.0

-37.0

-9.5

-21.1

 

 

 

 

 

 

    Other Financing Cash Flow

-0.3

0.0

0.0

-5.7

-10.6

Financing Cash Flow Items

-0.3

0.0

0.0

-5.7

-10.6

Total Cash Dividends Paid

-3.2

-3.3

-2.4

-1.9

-2.2

        Sale/Issuance of Common

-

5.2

-

-

5.8

    Common Stock, Net

-

5.2

-

-

5.8

Issuance (Retirement) of Stock, Net

-

5.2

-

-

5.8

        Short Term Debt Issued

117.9

147.2

114.7

37.2

31.1

        Short Term Debt Reduction

-159.6

-139.2

-103.4

-48.5

-14.7

    Short Term Debt, Net

-41.7

8.0

11.3

-11.3

16.5

        Long Term Debt Issued

89.0

69.7

13.9

26.1

27.8

        Long Term Debt Reduction

-17.7

-1.1

-0.5

-15.8

-21.8

    Long Term Debt, Net

71.3

68.6

13.5

10.4

6.0

Issuance (Retirement) of Debt, Net

29.7

76.5

24.8

-1.0

22.5

Cash from Financing Activities

26.2

78.4

22.4

-8.6

15.5

 

 

 

 

 

 

Foreign Exchange Effects

-

-0.1

0.0

-

-

Net Change in Cash

2.2

-2.1

1.5

0.4

2.8

 

 

 

 

 

 

Net Cash - Beginning Balance

3.9

6.0

4.3

3.4

1.2

Net Cash - Ending Balance

6.1

3.9

5.8

3.8

3.9

Cash Interest Paid

8.3

3.9

3.3

-

-

Cash Taxes Paid

1.0

4.9

5.2

-

-

 

 

 Annual Income Statement

 

Financials in: USD (mil)

Except for share items (millions) and per share items (actual units

 

 

 

31-Dec-2012

31-Dec-2011

31-Dec-2010

31-Dec-2009

31-Dec-2008

Period Length

12 Months

12 Months

12 Months

12 Months

12 Months

UpdateType/Date

Updated Normal 
31-Dec-2012

Reclassified Normal
31-Dec-2012

Restated Normal 
31-Dec-2011

Updated Normal 
31-Dec-2009

Reclassified Normal 
31-Dec-2009

Filed Currency

KRW

KRW

KRW

KRW

KRW

Exchange Rate (Period Average)

1126.848795

1107.891393

1156.281981

1276.385219

1100.562842

Auditor

Sahmduk Accounting Corp.

Sahmduk Accounting Corp.

Sahmduk Accounting Corp.

Sahmduk Accounting Corp.

Sungshin Accounting Corp.

Auditor Opinion

Unqualified with Explanation

Unqualified with Explanation

Unqualified with Explanation

Unqualified

Unqualified

 

 

 

 

 

 

    Sales Revenue of Merchandises

-

-

-

1.7

5.6

    Finished Products

-

-

-

112.8

104.7

    Sales Revenue

183.7

169.6

144.3

-

-

Total Revenue

183.7

169.6

144.3

114.5

110.3

 

 

 

 

 

 

    Cost of Merchandises Sold

-

-

-

1.7

5.5

    Cost of Finished Goods Sold

-

-

-

80.1

74.1

    Costs of Goods & Services Sold

148.0

126.5

105.1

-

-

    Salaries & Wages

6.4

5.6

4.1

3.6

3.6

    Retirement & Severance Benefits

0.4

0.4

0.3

0.4

0.5

    Employee Benefits

1.0

0.8

0.6

0.5

0.5

    Travel Expense

0.4

0.5

0.3

0.2

0.2

    Communication Expense

0.1

0.1

0.1

0.1

0.1

    Taxes & Dues

0.3

0.3

0.6

0.2

0.1

    Rental Expense

1.2

1.3

0.9

0.6

0.4

    Depreciation

0.4

0.4

0.4

0.5

0.5

    Repair Expense

0.1

0.2

0.1

0.1

0.1

    Insurance Expense

0.3

0.2

0.2

0.1

0.1

    Entertainment Expense

0.5

0.4

0.4

0.3

0.4

    Advertising Expense

0.4

0.4

0.4

0.2

0.3

    Commissions

0.9

0.5

1.0

0.8

0.4

    Consumable Expense

0.2

0.2

0.2

0.1

0.1

    Publication Expense

0.0

0.0

0.0

0.0

0.0

    Vehicle Maintenance Expense

0.6

0.5

0.4

0.3

0.3

    Shipping & Handling Expense

1.2

1.1

1.2

1.2

0.5

    Utility Expense

0.0

0.0

0.0

0.0

-

    Expense of Allow. for DA

0.2

0.3

0.3

0.2

-0.1

    Overseas Market Development Cost

0.3

0.3

0.3

0.3

0.2

    Education & Training Expense

0.0

0.0

0.0

0.0

0.0

    Packaging Expense

-

-

-

0.0

-

    Other Selling & Administrative Expense

-

0.1

0.1

0.2

0.1

    Amort. of Intangibless

-

-

-

0.5

0.5

    Exporting Expense

5.9

5.1

5.2

2.8

3.9

    Adj. for Other Selling & Admin. Expense

0.0

0.0

-

-

-

    Other Amortization

0.0

-

-

-

-

    Miscellaneous Expense

0.1

-

-

-

-

    R & D Expense

1.9

-

-

-

-

Total Operating Expense

170.9

145.3

122.2

95.3

92.3

 

 

 

 

 

 

    Interest Income

0.2

1.5

-

0.6

1.5

    Financial Assets-Interest Income

-

-

0.8

-

-

    Dividend Income

0.0

0.0

0.0

1.0

-

    Gain-Disposal of Sec. Avail. for Sale

-

0.0

-

-

-

    Gain on Foreign Currency Transaction

0.7

1.2

1.4

1.3

2.0

    Gain on Foreign Currency Translation

0.3

0.5

0.5

0.3

2.1

    Gain-Valt of Derivatives

-

-

-

-

1.3

    Gain on Disposal of PPE

5.6

0.1

6.5

0.0

0.0

    Gain on Disposal of Real Estate

-

0.5

-

-

-

    Loss-Disposal of F.A. Avail. for Sale

0.0

0.0

-1.4

-

-

    Loss-Disposal of Sec. Held-to-Maturity

0.0

-

-0.1

-

0.0

    Miscellaneous Income

0.7

0.8

0.5

0.5

1.0

    Rental Income

0.1

0.1

0.1

0.1

0.1

    Interest Expense, Non-Operating

-8.4

-4.0

-3.3

-3.9

-5.4

    Loss-Derivatives Transaction

-

-

-

-

-3.9

    Loss-Valuation of Derivatives

-

-

-

-0.2

-

    Loss-Redemption of Debentures

-

-

-

-

-0.4

    Loss on Foreign Currency Transaction

-1.6

-1.9

-2.4

-1.4

-0.6

    Loss on Foreign Currency Translation

-0.4

-1.5

-1.2

-1.1

-1.5

    Loss-Reduction of Intangible Assets

-

-

-

-0.8

-

    Donations Paid

0.0

-0.7

0.0

-0.1

0.0

    Loss on Disposal of PPE

-0.3

-0.1

-2.0

-0.1

-0.1

    Loss on Disposal of Non-Current Assets

-

-

0.0

-

-

    Loss on Scrapping of Inventory

-0.4

-0.4

-0.3

-0.2

-0.1

    Miscellaneous Loss

-0.2

-0.1

0.0

0.0

0.0

    Depreciation of Real Estate

-

0.0

0.0

-

-

    Loss under Equity Method

-

-

-

-0.2

-

    Gain on Invmt in Affiliates

0.9

2.0

-2.4

-

-

    Adj. for Finance Income

0.0

0.0

0.0

-

-

    Adj. for Finance Expense

0.0

0.0

-

-

-

    Adj. for Other Non-Operating Income

0.0

0.0

0.0

-

-

    Adj. for Other Non-Operating Expense

0.0

0.0

0.0

-

-

    Gain on Insurance Settlement

1.9

-

-

-

-

    Loss on Reduction of Assets Held for Sal

-16.8

-

-

-

-

Net Income Before Taxes

-5.0

22.1

18.6

15.0

14.0

 

 

 

 

 

 

Prov. for Income Taxes

-2.9

4.4

4.2

4.6

4.2

Net Income After Taxes

-2.1

17.7

14.5

10.4

9.8

 

 

 

 

 

 

    Minority Interest

-1.7

-1.5

-1.4

-0.7

-0.1

Net Income Before Extra. Items

-3.8

16.2

13.0

9.7

9.7

Net Income

-3.8

16.2

13.0

9.7

9.7

 

 

 

 

 

 

Income Available to Com Excl ExtraOrd

-3.8

16.2

13.0

9.7

9.7

 

 

 

 

 

 

Income Available to Com Incl ExtraOrd

-3.8

16.2

13.0

9.7

9.7

 

 

 

 

 

 

Basic Weighted Average Shares

11.3

11.2

11.1

10.8

10.7

Basic EPS Excluding ExtraOrdinary Items

-0.34

1.45

1.18

0.89

0.90

Basic EPS Including ExtraOrdinary Items

-0.34

1.45

1.18

0.89

0.90

Dilution Adjustment

0.0

0.0

0.0

0.0

0.1

Diluted Net Income

-3.8

16.2

13.0

9.7

9.7

Diluted Weighted Average Shares

11.3

11.2

11.1

10.8

11.1

Diluted EPS Excluding ExtraOrd Items

-0.34

1.45

1.18

0.89

0.88

Diluted EPS Including ExtraOrd Items

-0.34

1.45

1.18

0.89

0.88

DPS-Ordinary Shares

0.13

0.25

0.24

0.20

0.21

Gross Dividends - Common Stock

1.5

2.9

2.7

2.2

2.2

Normalized Income Before Taxes

-9.9

22.5

14.4

15.7

14.7

 

 

 

 

 

 

Inc Tax Ex Impact of Sp Items

-4.6

4.4

3.2

4.7

4.3

Normalized Income After Taxes

-5.3

18.0

11.2

11.0

10.4

 

 

 

 

 

 

Normalized Inc. Avail to Com.

-7.0

16.5

9.8

10.3

10.3

 

 

 

 

 

 

Basic Normalized EPS

-0.62

1.48

0.88

0.95

0.96

Diluted Normalized EPS

-0.62

1.48

0.88

0.95

0.94

Interest Expense, Supplemental

8.4

4.0

3.3

3.9

5.4

Rental Expense, Supplemental

1.2

1.3

0.9

0.6

0.4

Advertising Expense, Supplemental

0.4

0.4

0.4

0.2

0.3

Research & Development Exp

1.9

-

-

-

-

Amort of Intangibles, Supplemental

0.0

0.0

0.0

0.0

0.0

Amort of Acquisition Cost

-

-

-

0.5

0.5

Depreciation, Supplemental

13.1

7.0

7.7

8.1

6.7

 

 

Annual Balance Sheet

 

Financials in: USD (mil)

 

 

 

 

31-Dec-2012

31-Dec-2011

31-Dec-2010

31-Dec-2009

31-Dec-2008

UpdateType/Date

Updated Normal 
31-Dec-2012

Updated Normal 
31-Dec-2011

Restated Normal 
31-Dec-2011

Updated Normal 
31-Dec-2009

Reclassified Normal 
31-Dec-2009

Filed Currency

KRW

KRW

KRW

KRW

KRW

Exchange Rate

1066.400024

1152

1134.9

1164.475

1259.55

Auditor

Sahmduk Accounting Corp.

Sahmduk Accounting Corp.

Sahmduk Accounting Corp.

Sahmduk Accounting Corp.

Sahmduk Accounting Corp.

Auditor Opinion

Unqualified with Explanation

Unqualified with Explanation

Unqualified with Explanation

Unqualified

Unqualified

 

 

 

 

 

 

    Cash & Cash Equivalents

6.4

3.8

5.9

4.2

3.4

    ST Finl Assets

-

-

-

3.2

14.8

    Security Held to Maturity

-

-

-

0.2

0.0

    Other Current Fincl Instrm

1.5

-

0.3

-

-

    Trade Receivable, Gross

45.5

29.3

35.9

32.4

25.3

    Allow. for DA for Trade Receivable

-0.5

-0.4

-0.5

-0.7

-0.4

    Loans

-

0.1

0.1

1.1

0.1

    Account Receivable

1.8

1.6

1.4

2.0

3.0

    Accrued Income

0.1

0.0

0.0

0.2

0.4

    Advance Payments

2.7

1.3

-

1.0

0.9

    Prepaid Expense

0.5

0.2

-

1.6

2.1

    Deferred Income Taxes Assets

-

-

-

0.4

0.1

    Current Tax Assets

0.6

0.0

0.0

0.3

0.2

    Derivatives

-

-

-

0.7

-

    Merchandises

0.2

0.1

0.1

4.3

1.9

    Finished Goods

24.2

18.2

18.5

11.5

10.4

    Work in Progress

6.8

6.6

3.2

2.0

1.9

    Raw Materials

22.9

17.0

12.9

9.1

10.5

    Supplies

0.8

0.7

0.5

0.4

0.3

    Goods in Transit

3.2

4.3

2.6

4.8

0.6

    Other Current Assets

-

-

1.1

0.0

-

    Adj. for Inventories

0.0

0.0

-

-

-

    Adj. for Trade Receivable

0.0

-

0.0

-

-

    Adj. for Other Receivable

0.0

0.0

0.0

-

-

    Adj. for Other Current Assets

0.0

0.0

-

-

-

Total Current Assets

116.6

82.9

82.1

78.7

75.6

 

 

 

 

 

 

    LT Finl Assets

-

-

-

0.2

0.1

    Non-Current Securities Available-for-Sal

0.0

0.2

0.5

1.9

1.5

    Derivatives, assets

-

-

-

-

1.2

    Invmt in Properties

-

2.9

2.6

-

-

    Loans

0.2

4.8

4.3

8.6

8.6

    Non-Current Other Receivable

-

-

0.0

-

-

    Non-Current Securities Held-to-Maturitie

0.4

0.4

0.4

1.6

0.3

    Other Non-Current Fincl Instrm

1.3

1.5

1.5

-

-

    Securities under Equity Method

-

-

-

4.6

6.3

    Invmt in Affiliates

7.2

6.6

5.7

-

-

    Guarantee Deposits, Non-Current Assets

0.9

0.7

0.6

0.4

0.4

    Other Non-Current Assets

0.8

0.9

0.9

-

0.0

    Membership Right

-

-

-

1.9

1.6

    Non-Current Deferred Income Taxes Assets

0.1

-

-

1.9

1.8

    Land

73.3

113.5

111.6

42.5

25.6

    Buildings

110.1

42.5

34.2

31.1

29.0

    Buildings Depre.

-8.6

-16.6

-15.8

-11.2

-9.0

    Structures

-

-

-

5.0

4.5

    Structure Depre.

-

-

-

-3.7

-3.1

    Machineries & Equipments

156.0

100.0

95.6

95.1

82.3

    Machineries & Equipments-Depreciation

-84.0

-69.5

-67.1

-61.9

-51.7

    Machineries & Equipments-Govern. Subsidy

-1.1

-

-

-

-

    Transport Equip.

-

-

-

1.5

1.2

    Transport Deprec

-

-

-

-1.0

-0.8

    Construction in Progress

5.6

97.6

33.6

8.4

16.9

    Other Property Plant & Equipment

21.0

12.0

11.6

11.6

8.6

    Other Property Plant & Equipment-Depreci

-11.4

-9.1

-9.1

-7.9

-6.4

    Other Tangibles-Government Subsidy

-0.1

-

-

-

-

    Development Cost

0.5

0.4

0.4

7.6

6.5

    Software

0.1

0.1

0.1

-

-

    Land Usufruct

2.0

2.0

2.1

-

-

    Other Intangibless

-

-

-

1.3

1.3

    Facilities Usage Rights

3.6

3.3

2.5

-

-

    Negative Goodwill

-

-

-

1.0

1.3

    Current Assets Held for Sale

42.9

-

-

-

-

    Adjustment for Property, Plant & Equipme

0.0

0.0

0.0

-

-

    Adj. for Intangibless

0.0

0.0

0.0

-

-

    Adj. for Other Non-Current Receivable

-

0.0

0.0

-

-

Total Assets

437.4

376.9

298.2

219.2

203.8

 

 

 

 

 

 

    Current Trade Payable

12.1

1.5

8.7

1.0

4.7

    ST Borrowings

44.2

70.0

58.3

21.8

31.6

    Other Payable

3.5

3.8

1.6

7.6

1.5

    Current Portion of Long-term Debt

4.6

12.9

12.5

8.1

6.0

    Capital Leased Liabilities,

-

1.0

-

-

-

    Current Portion of Bonds

-

-

-

25.8

1.6

    Advance from Customers

4.5

0.2

-

1.0

2.4

    Unearned Income

0.0

0.1

-

-

0.3

    Accrued Expense

1.9

1.5

0.7

0.7

0.6

    Current Tax Liabilities

1.9

0.6

3.5

4.3

1.3

    Deferred Income Tax Credits

-

-

-

-

0.4

    Withheld

0.3

1.1

-

0.1

0.1

    Derivatives in Current Liabilities

-

-

-

0.1

-

    Other Current Liabilities

-

-

0.4

-

-

    Adj. for Other Current Payable

0.0

0.0

0.0

-

-

    Adjustment for Current Borrowings & Bond

0.0

0.0

0.0

-

-

    Adj. for Other Current Liabilities

0.0

0.0

-

-

-

Total Current Liabilities

72.8

92.7

85.6

70.4

50.5

 

 

 

 

 

 

    Non-Current Borrowings

81.4

70.7

26.3

28.3

49.4

    Bonds

84.4

17.4

-

-

-

    Capital Leased Liabilities, LD

0.5

-

2.4

-

-

    Adjustment-Non-Current Borrowings & Bond

0.0

0.0

0.0

-

-

Total Long Term Debt

166.3

88.0

28.6

28.3

49.4

 

 

 

 

 

 

    Derivative Products in Liabilities

-

-

-

-

0.2

    Rental Guarantee Deposit, LT Liabilities

0.2

0.4

1.5

1.7

1.5

    Deferred Income Taxes, LT Liabilities

9.7

14.2

12.5

-

0.0

    Non-Current Fixed Benefit Liabilities

0.9

9.1

6.8

-

-

    Prov.for Retirement & Severance Benefits

-

-

-

8.6

7.1

    Deposit for Retirement Insurance

-

-7.4

-0.1

-5.4

-4.2

    Plan Assets, Non-Current Liabilities

-

-1.4

-6.6

-0.9

-

    Transfer to National Pension Funds

-

0.0

0.0

-0.1

0.0

    Minority Interests

21.3

18.4

17.8

12.3

9.6

Total Liabilities

271.2

214.0

146.2

115.0

114.2

 

 

 

 

 

 

    Common Stock

5.7

5.3

5.4

5.2

4.7

    Additional Paid in Capital

7.6

7.1

7.2

7.0

4.9

    Other Capital Surplus

-

-

-

3.4

3.2

    Treasury Stock

-1.2

-1.2

-2.3

-2.3

-2.1

    Other Capital Adjustment

-

-

-

-0.5

0.0

    Retained Earnings

123.8

122.4

111.9

-

-

    Legal Reserve

-

-

-

2.5

2.4

    Voluntary Reserve

-

-

-

50.0

39.3

    Unappropriated Retained Earnings

-

-

-

11.0

9.2

    Overseas Business Trans. Debit/Credit

-2.1

-0.8

0.1

0.0

2.4

    Gains on Disposal of Treasury Stock

4.2

3.9

3.2

-

-

    Disc.s on Stock Issuance

-0.1

0.0

0.0

-

-

    Capital Change, Equity Method (Loss)

-

-

-

0.0

-

    Loss-Valuation of Derivatives

-

-

-

0.0

-0.1

    Resv for Assets ReValt

28.4

26.3

26.6

27.8

25.7

    Adj. for Capital Surplus

0.0

0.0

0.0

-

-

    Adj. for Other Capital

0.0

0.0

0.0

-

-

Total Equity

166.2

162.9

152.0

104.2

89.6

 

 

 

 

 

 

Total Liabilities & Shareholders' Equity

437.4

376.9

298.2

219.2

203.8

 

 

 

 

 

 

    S/O-Ordinary Shares

11.3

11.3

11.1

11.1

10.7

Total Common Shares Outstanding

11.3

11.3

11.1

11.1

10.7

T/S-Ordinary Shares

0.3

0.3

0.5

0.5

0.5

Deferred Revenue, Current

4.5

0.3

-

1.0

2.7

Accumulated Intangible Amort, Suppl.

1.1

1.0

1.0

0.0

-

Accumulated Goodwill Amortization, Suppl

-

-

-

1.6

-

Full-Time Employees

674

598

564

556

539

Number of Common Shareholders

-

2,423

2,323

2,532

2,369

Long Term Debt Maturing within 1 Year

4.6

13.9

-

33.9

6.0

Long Term Debt Maturing within 2 Years

9.2

29.5

-

13.1

15.2

Long Term Debt Maturing within 3 Years

15.8

6.1

-

14.8

7.9

Long Term Debt Maturing in Year 5

11.0

8.8

-

-

-

Long Term Debt Remaining Maturities

46.0

43.6

-

0.3

19.4

Total Long Term Debt, Supplemental

86.5

102.0

-

62.2

48.4

Capital Leases Due within 1 Year

0.0

1.0

0.9

-

0.0

Capital Leases Due within 2 Years

-

-

-

-

0.0

Capital Lease Payments Due in Year 5

0.5

-

1.4

-

-

Total Capital Leases, Supplemental

0.5

1.0

2.4

-

0.0

Operating Lease Pymts. Due within 1Year

0.2

0.2

-

-

-

Operating Lease Payments Due in Year 5

0.1

0.2

-

-

-

Total Operating Leases, Supplemental

0.2

0.4

-

-

-

 


Annual Cash Flows

 

Financials in: USD (mil)

 

 

 

31-Dec-2012

31-Dec-2011

31-Dec-2010

31-Dec-2009

31-Dec-2008

Period Length

12 Months

12 Months

12 Months

12 Months

12 Months

UpdateType/Date

Updated Normal 
31-Dec-2012

Updated Normal 
31-Dec-2011

Restated Normal 
31-Dec-2011

Updated Normal 
31-Dec-2009

Updated Normal 
31-Dec-2008

Filed Currency

KRW

KRW

KRW

KRW

KRW

Exchange Rate (Period Average)

1126.848795

1107.891393

1156.281981

1276.385219

1100.562842

Auditor

Sahmduk Accounting Corp.

Sahmduk Accounting Corp.

Sahmduk Accounting Corp.

Sahmduk Accounting Corp.

Sungshin Accounting Corp.

Auditor Opinion

Unqualified with Explanation

Unqualified with Explanation

Unqualified with Explanation

Unqualified

Unqualified

 

 

 

 

 

 

Net Income or Loss

-2.1

17.7

14.5

10.4

9.8

    Depreciation

13.1

7.0

7.7

8.1

6.7

    Amort. of Intangibless

0.0

0.0

0.0

0.5

0.6

    Payment for Retirement Allow., ONCI

1.9

1.6

1.6

1.6

2.4

    Amort-Convertible Right Adjustment

-

-

-

0.0

0.5

    Amortization-Discount on Bond Issuance

-

-

-

0.0

0.1

    Depreciation of Real Estate

0.0

0.0

0.0

-

-

    Other Amort.

0.0

-

-

-

-

    Expense of Allow. for DA

0.2

0.3

0.3

0.2

0.1

    Loss-Scrap of Tangible Assets

-

-

-

-

0.0

    Loss on Disposal of Property, Plant and

0.3

0.1

2.0

0.1

0.0

    Losses on Foreign Currency Translation

0.4

1.5

1.2

1.1

1.5

    Loss-Redemption of Bond

-

-

-

-

0.4

    Loss-Valuation of Derivatives

-

-

-

0.2

-

    Losses on Valt of Inventories

-

-

-

0.0

-

    L-Disposal of Financial Assets Avai. Sal

0.0

0.0

1.4

-

-

    L-Disposal of Financial Assets Held to M

0.0

-

0.1

-

0.0

    Loss-Reduction of Intangible Assets

-

-

0.0

0.8

-

    Loss on Scraping of Inventory

0.4

0.4

0.3

0.2

0.1

    Loss under Equity Method

-

-

-

0.2

-

    Loss on Invesment in Affiliates

-

-

2.4

-

-

    Gain on Disposal of Property, Plant and

-5.6

-0.1

-6.5

0.0

0.0

    Recovery-Inventory Valuation Loss

-

-

-

-

0.0

    Gains on Foreign Currency Translation

-0.3

-0.5

-0.5

-0.3

-2.0

    Gain on Invesment in Affiliates

-0.9

-2.0

-

-

-

    G-Disposal of Financial Assets Avail. Sa

0.0

0.0

-

-

-

    Gain on Disposal of Investment Propertie

0.0

-0.5

-

-

-

    Gain-Derivatives Valuation

-

-

-

-

-1.3

    Revers-Doubtful Acct

-

-

-

-

-0.1

    Interest Expenses

8.4

4.0

3.3

-

-

    Interest Income

-0.2

-0.4

-0.8

-

-

    Dividend Income

0.0

0.0

0.0

-

-

    Rec. of PV Disc.

0.0

-1.1

-

-

-

    Corporate Taxes Expense

-2.9

2.0

3.9

-

-

    Impmt Loss on Assets Held for Sale

16.8

-

-

-

-

    Inventory

-8.6

-10.7

-5.4

-4.3

-5.0

    Trade Receivables

1.2

6.2

-4.6

-4.8

2.3

    Accrued Income

-

-

-

0.2

0.1

    Other Current Receivables

0.0

-0.6

2.3

-

-

    Other Non-Current Receivables

4.5

-0.6

4.1

-

-

    Advance Payments

-

-

-

0.0

0.0

    Prepaid Expenses

-

-

-

0.6

-1.1

    Account Receivables

-

-

-

1.3

-2.6

    Prepaid Taxes

-

-

-

-0.1

0.0

    Current Tax Assets

0.0

0.0

0.0

-

-

    Other Current Assets

-1.5

-0.3

0.1

0.0

-

    Other Non-Current Assets

-0.3

0.0

0.1

-

-

    Payment for Retirement Allow.

-0.9

-0.5

-3.7

-0.8

-1.4

    National Pension Fund

0.0

0.0

0.0

0.0

0.0

    Retirement Insurance

-

-

-

-0.8

-0.5

    Retirement Pension Operating Fund

-

-

-

-0.9

-

    Retirement Pension Assets

-2.3

-1.9

-0.2

-

-

    Other Current Liabilities

-0.9

0.8

-1.9

-

-

    Deferred Income Taxes Assets

-0.1

0.0

-0.3

-0.1

-0.5

    Trade Payable

-4.5

-7.4

2.1

-2.1

-5.8

    LT Trade Payable, A/L

-

-

-

-

3.3

    Account Payables

-

-

-

5.4

0.6

    Other Current Payable

-0.3

1.4

-0.4

-

-

    Other Non-Current Payable

-0.2

-1.1

-0.5

-

-

    Advances Received

-

-

-

-0.7

2.6

    Non-Current Prov.s

0.0

0.0

-

-

-

    Accrued Expenses

-

-

-

0.0

0.0

    Accrued Income Tax

-

-

-

2.7

-2.9

    Current Tax Liabilities

-

-

0.6

-

-

    Deferred Income Taxes Liabilities

-0.1

2.6

-0.2

-0.4

0.1

    Unearned Income

-

-

-

-0.1

0.4

    Deposits Withheld

-

-

-

0.0

0.0

    Cash-Interest Received

0.2

0.3

0.5

-

-

    Cash-Dividend Income

0.0

0.0

0.7

-

-

    Cash-Interest Paid

-8.3

-3.9

-3.3

-

-

    Cash-Tax Paid

-1.0

-4.9

-5.2

-

-

    Adj. for Added Expense/Deducted Income

0.0

0.0

0.0

-

-

    Adj. for A/L Change from Operations

0.0

-

-

-

-

Cash from Operating Activities

6.6

9.6

16.1

18.6

8.4

 

 

 

 

 

 

    Disposal of Current Trading Securities

-

-

0.9

-

-

    Disposal-Securities Available-for-Sale

0.1

0.7

0.3

-

-

    Disp-Secs held till Maturity

0.0

-

1.3

0.0

0.0

    Dec-ST Loans

-

-

-

0.2

0.1

    Disposal of Investment Properties

-

2.8

-

-

-

    Disposal of Current Trading Securities

-

0.0

0.0

-

-

    Disposal of Current Financial Instrument

4.4

4.4

4.2

24.9

25.4

    Decrease-Derivatives Assets

-

-

-

0.3

0.0

    Disposal of Other Non-Current Financial

-

-

0.0

-

-

    Dec-Guarantee Dep

-

-

-

0.0

0.1

    Dividend Received

0.6

1.0

-

-

-

    Disp-Building

-

-

-

-

0.0

    Disp-Machinery

-

-

-

0.2

0.2

    Disposal-Transportation

-

-

-

0.0

0.0

    Disposal-Construction in Progress

-

-

-

0.1

7.2

    Disposal of Property, Plant and Equipmen

11.9

0.4

10.2

-

-

    Decrease in LT Loans

-

-

-

0.0

0.0

    Purchase of Current Trading Sec.

-

-

-0.9

-

-

    Increase-Loans

-

-

-

-0.7

-0.1

    Purchase of Other ST Finacial Instrm

-

-

-

-13.2

-19.4

    Inc-LT Finl Assets

-

-

-

-0.1

-0.1

    Purchase of Other Current Finacial Instr

-5.1

-4.1

-1.9

-

-

    Purchase of Other LT Fincl Instrm

-0.4

-0.4

-1.3

-

-

    Purchase of Sec. Available-for-Sale

0.0

-0.3

0.0

-

-

    Purchase of Fincl Asset Held to Maturity

-

0.0

-0.5

-1.4

0.0

    Purchase of Equity Method Sec.

-

-

-

-0.5

-

    Purchase of Invmt in Affiliates

-0.3

-3.0

-2.0

-

-

    Inc in Guarant Depos

-

-

-

0.0

0.0

    Increase-Membership Right

-

-

-

-0.2

-0.1

    Increase-Investment Advanced Payment

-

-

-

-0.1

-

    Purchase of Land

-

-

-

-0.4

0.0

    Purchase of Buildings

-

-

-

0.0

-

    Purchase of Structures

-

-

-

-0.1

0.0

    Purchase of Machinery

-

-

-

-6.6

-21.9

    Purchase of Vehicles

-

-

-

-0.2

-0.3

    Purchase of Construction in Progress

-

-

-

-10.4

-10.5

    Acq. Other Tangible

-

-

-

-0.6

-0.3

    Purchase of Tangibles

-45.7

-90.5

-46.8

-

-

    Purchase of Intangibless

0.0

-0.9

-0.7

-

-

    Purchase of Development Costs

-

-

-

-0.7

-1.3

    Purchase of Other Intangibless

-

-

-

0.0

-

    Advance from Sale of Tangible Assets

4.1

-

-

-

-

Cash from Investing Activities

-30.6

-90.0

-37.0

-9.5

-21.1

 

 

 

 

 

 

    Increase in Current Borrowings&Bonds

117.9

147.2

114.7

-

-

    Inc in ST Borrowings

-

-

-

37.2

31.1

    Increase in Non-Current Borrowings&Bonds

89.0

69.7

13.9

-

-

    Inc in LT Borrowings

-

-

-

2.6

27.8

    Increase in Bonds

-

-

-

23.5

-

    Inc Lease Guarantee

-

-

-

0.1

0.0

    Rights Issue

-

3.0

-

-

5.8

    Decrease in Treasury Stocks

-

2.2

-

-

-

    Cash Inflow-Consoli. Capital Transaction

-

-

-

0.6

-

    Repay ST Borrowings

-

-

-

-48.5

-14.7

    Decrease in Current Borrowings&Bonds

-159.6

-139.2

-103.4

-

-

    Decrease in Non-Current Borrowings&Bonds

-17.7

-1.1

-0.5

-

-

    Redemption-Bond

-

-

-

0.0

-9.1

    Decrease-Current Portion of Bond

-

-

-

-

-1.8

    Decrease-Convertible Bond

-

-

-

-

-10.4

    Dec-Current Portion of LT Liabilities

-

-

-

-5.9

-10.9

    Dec in LT Borrowings

-

-

-

-15.8

-0.5

    Dec-Rent Deposits

-

-

-

0.0

-0.1

    Dividend Paid

-3.2

-3.3

-2.4

-1.9

-2.2

    Cash Inflow-Consol. Scope Change, FN

-

-

-

-

1.4

    Increase in Stocks Issuance Cost

0.0

0.0

0.0

0.0

0.0

    Cash Outflow-Consol. Capital Transaction

-

-

-

-

-1.8

    Inc-Overseas Business Translation Debit

-

-

-

-0.5

0.8

    Incs in Retm&Sevr Benf Benefit Resv

0.0

0.0

-

-

-

    Increase in Government Subsidy

1.3

-

-

-

-

    Decrease in Government Subsidy

-1.3

-

-

-

-

    Cash Flow-Foreign Currency Translation

-0.3

-

-

-

-

Cash from Financing Activities

26.2

78.4

22.4

-8.6

15.5

 

 

 

 

 

 

Foreign Exchange Effects

-

-0.1

0.0

-

-

Incs or Decs in Cash & Cash Equivalents

2.2

-2.1

1.5

0.4

2.8

 

 

 

 

 

 

Cash and Cash Equivalents at Beginning

3.9

6.0

4.3

3.4

1.2

Cash and Cash Equivalents at End

6.1

3.9

5.8

3.8

3.9

    Cash Interest Paid

8.3

3.9

3.3

-

-

    Cash Taxes Paid

1.0

4.9

5.2

-

-

 

 

Financial Health

 

Financials in: USD (mil)

Except for share items (millions) and per share items (actual units)

 


Key Indicators USD (mil)

 

Quarter
Ending
30-Jun-2013

Quarter
Ending
Yr Ago

Annual
Year End
31-Dec-2012

1 Year
Growth

3 Year
Growth

5 Year
Growth

Total Revenue1 (?)

61.8

29.95%

183.7

10.20%

12.31%

17.06%

Research & Development1 (?)

0.6

-23.66%

1.9

-

-

-

Operating Income1 (?)

7.9

75.99%

12.8

-46.39%

-16.15%

3.15%

Income Available to Common Excl Extraord Items1 (?)

4.7

28.93%

-3.8

-

-

-

Basic EPS Excl Extraord Items1 (?)

0.41

28.93%

-0.34

-

-

-

Capital Expenditures2 (?)

13.2

-55.57%

45.8

-49.03%

28.61%

24.99%

Cash from Operating Activities2 (?)

-3.9

-

6.6

-30.09%

-32.13%

-10.92%

Free Cash Flow (?)

-16.4

-

-41.4

-

-

-

Total Assets3 (?)

437.9

-

437.4

7.42%

22.26%

19.40%

Total Liabilities3 (?)

276.3

-

271.2

17.30%

29.27%

26.09%

Total Long Term Debt3 (?)

148.2

-

166.3

74.89%

75.33%

38.29%

Employees3 (?)

-

-

674

12.71%

6.63%

4.65%

Total Common Shares Outstanding3 (?)

11.3

-

11.3

0.00%

0.75%

1.12%

1-ExchangeRate: KRW to USD Average for Period

1122.022568

 

1126.848795

 

 

 

2-ExchangeRate: KRW to USD Average for Period

1103.219597

 

1126.848795

 

 

 

3-ExchangeRate: KRW to USD Period End Date

1147.202838

 

1066.400024

 

 

 

 

 

Key Ratios

 

31-Dec-2012

31-Dec-2011

31-Dec-2010

31-Dec-2009

31-Dec-2008

Profitability

Gross Margin (?)

19.46%

25.40%

27.15%

28.61%

27.87%

Operating Margin (?)

6.97%

14.32%

15.30%

16.74%

16.38%

Pretax Margin (?)

-2.71%

13.01%

12.91%

13.09%

12.70%

Net Profit Margin (?)

-2.09%

9.55%

9.01%

8.44%

8.76%

Financial Strength

Current Ratio (?)

1.60

0.89

0.96

1.12

1.50

Long Term Debt/Equity (?)

1.00

0.54

0.19

0.27

0.55

Total Debt/Equity (?)

1.29

1.06

0.65

0.81

0.99

Interest Coverage (?)

-

107,639,800.20

85,082,672.50

-

-

Management Effectiveness

Return on Assets (?)

-0.53%

5.08%

5.63%

5.16%

4.80%

Return on Equity (?)

-2.38%

9.96%

10.24%

10.54%

9.92%

Efficiency

Receivables Turnover (?)

4.86

4.87

4.04

3.82

3.94

Inventory Turnover (?)

2.77

2.84

2.99

2.91

2.93

Asset Turnover (?)

0.46

0.49

0.56

0.57

0.54

 

 

Market Valuation USD (mil)

Enterprise Value2 (?)

636.7

.

Enterprise Value/Revenue (TTM) (?)

3.41

Price/Book (MRQ) (?)

2.44

.

Enterprise Value/EBITDA (TTM) (?)

24.15

Market Cap as of 22-Nov-20131 (?)

435.5

.

 

 

1-ExchangeRate: KRW to USD on 22-Nov-2013

1062.683289

 

 

 

2-ExchangeRate: KRW to USD on 30-Jun-2013

1147.202838

 

 

 

 

 

 

 Annual Ratios

 

Financials in: USD (mil)

Except for share items (millions) and per share items (actual units)

 

 

31-Dec-2012

31-Dec-2011

31-Dec-2010

31-Dec-2009

31-Dec-2008

Financial Strength

Current Ratio (?)

1.60

0.89

0.96

1.12

1.50

Quick/Acid Test Ratio (?)

0.75

0.37

0.50

0.60

0.93

Working Capital1 (?)

43.8

-9.9

-3.6

8.3

25.1

Long Term Debt/Equity (?)

1.00

0.54

0.19

0.27

0.55

Total Debt/Equity (?)

1.29

1.06

0.65

0.81

0.99

Long Term Debt/Total Capital (?)

0.44

0.26

0.11

0.15

0.28

Total Debt/Total Capital (?)

0.56

0.51

0.40

0.45

0.50

Interest Coverage (?)

-

107,639,800.20

85,082,672.50

-

-

Payout Ratio (?)

-39.16%

17.47%

20.61%

21.97%

23.16%

Effective Tax Rate (?)

-

19.76%

22.44%

30.92%

30.20%

Total Capital1 (?)

381.3

334.9

251.4

188.2

178.3

 

 

 

 

 

 

Efficiency

Asset Turnover (?)

0.46

0.49

0.56

0.57

0.54

Inventory Turnover (?)

2.77

2.84

2.99

2.91

2.93

Days In Inventory (?)

131.77

128.32

122.28

125.53

124.38

Receivables Turnover (?)

4.86

4.87

4.04

3.82

3.94

Days Receivables Outstanding (?)

75.15

74.98

90.38

95.66

92.59

Revenue/Employee2 (?)

288,035

272,710

260,700

225,729

178,884

Operating Income/Employee2 (?)

20,070

39,062

39,877

37,797

29,293

EBITDA/Employee2 (?)

40,694

50,344

53,924

53,898

40,264

 

 

 

 

 

 

Profitability

Gross Margin (?)

19.46%

25.40%

27.15%

28.61%

27.87%

Operating Margin (?)

6.97%

14.32%

15.30%

16.74%

16.38%

EBITDA Margin (?)

14.13%

18.46%

20.68%

23.88%

22.51%

EBIT Margin (?)

6.97%

14.32%

15.30%

16.74%

16.38%

Pretax Margin (?)

-2.71%

13.01%

12.91%

13.09%

12.70%

Net Profit Margin (?)

-2.09%

9.55%

9.01%

8.44%

8.76%

R&D Expense/Revenue (?)

1.05%

-

-

-

-

COGS/Revenue (?)

80.54%

74.60%

72.85%

71.39%

72.13%

SG&A Expense/Revenue (?)

11.20%

10.81%

11.56%

11.04%

10.53%

 

 

 

 

 

 

Management Effectiveness

Return on Assets (?)

-0.53%

5.08%

5.63%

5.16%

4.80%

Return on Equity (?)

-2.38%

9.96%

10.24%

10.54%

9.92%

 

 

 

 

 

 

Valuation

Free Cash Flow/Share2 (?)

-3.66

-6.95

-2.89

-0.04

-2.12

Operating Cash Flow/Share 2 (?)

0.61

0.81

1.48

1.84

0.68

1-ExchangeRate: KRW to USD Period End Date

1066.400024

1152

1134.9

1164.475

1259.55

2-ExchangeRate: KRW to USD Average for Period

1066.400024

1152

1134.9

1164.475

1259.55

 

Current Market Multiples

Market Cap/Equity (MRQ) (?)

2.50

Enterprise Value/Equity (MRQ) (?)

3.94

 


 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.62.38

UK Pound

1

Rs.102.15

Euro

1

Rs.85.29

 

 

INFORMATION DETAILS

 

Report Prepared by :

NNA

 

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

----

NB

New Business

----

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.